China SXT Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
China SXT Pharmaceuticals, Inc. (SXTC) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$495.55 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2025-07-31
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-03-31 | -$495.55K 20-F · filed 2025-07-31 |
| 2024-03-31 | -$404.48K 20-F · filed 2025-07-31 |
| 2023-03-31 | -$653.07K 20-F · filed 2025-07-31 |
| 2022-03-31 | -$811.19K 20-F · filed 2024-08-13 |
| 2021-03-31 | -$441.13K 20-F · filed 2023-07-31 |
| 2020-03-31 | -$1.56M 20-F/A · filed 2023-05-19 |
| 2019-03-31 | $268.72K 20-F · filed 2021-08-13 |
| 2018-03-31 | $406.92K 20-F · filed 2020-07-31 |
| 2017-03-31 | $395.05K 20-F · filed 2019-08-15 |